Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2626
Applied Optoelectronics
AAOI
$9.31B
| $850K | ﹤0.01% |
+78,200
| New | +$717K |
2020 Q2
0 quarters
|
|
2627
Covenant Logistics
CVLG
$811M
| $850K | ﹤0.01% |
+117,800
| New | +$600K |
2020 Q2
0 quarters
|
|
2628
Monro
MNRO
$424M
| $850K | ﹤0.01% |
+15,479
| New | +$824K |
2020 Q2
0 quarters
|
|
2629
First Trust Senior Loan Fund ETF
FTSL
$2.43B
| $844K | ﹤0.01% |
+18,700
| New | +$836K |
2020 Q2
0 quarters
|
|
2630
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.7B
| $844K | ﹤0.01% |
+2,600
| New | +$788K |
2020 Q2
0 quarters
|
|
2631
TAT Technologies
TATT
$441M
| $843K | ﹤0.01% |
212,900
+2,400
| +1% | +$9.17K |
2013 Q2
28 quarters
|
|
2632
Franklin Electric
FELE
$4.32B
| $840K | ﹤0.01% |
+16,000
| New | +$795K |
2020 Q2
0 quarters
|
|
2633
iShares Core S&P Small-Cap ETF
IJR
$104B
| $840K | ﹤0.01% |
+12,300
| New | +$777K |
2020 Q2
0 quarters
|
|
2634
Arcutis Biotherapeutics
ARQT
$3.34B
| $838K | ﹤0.01% |
+27,700
| New | +$801K |
2020 Q2
0 quarters
|
|
2635
NexPoint Real Estate Finance
NREF
$290M
| $838K | ﹤0.01% |
+50,000
| New | +$662K |
2020 Q2
0 quarters
|
|
|
CYRN
2636
DELISTED
CYREN Ltd.
CYRN
| $838K | ﹤0.01% |
35,494
+1,985
| +6% | +$42K |
2013 Q2
28 quarters
|
|
2637
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.93B
| $837K | ﹤0.01% |
+12,100
| New | +$786K |
2020 Q2
0 quarters
|
|
2638
Ohio Valley Banc Corp
OVBC
$211M
| $837K | ﹤0.01% |
37,100
-4,400
| -11% | -$110K |
2016 Q2
16 quarters
|
|
2639
DSS Inc
DSS
$6.08M
| $832K | ﹤0.01% |
5,482
+4,415
| +414% | +$677K |
2017 Q2
12 quarters
|
|
2640
Octave Specialty Group
OSG
$208M
| $829K | ﹤0.01% |
57,900
-55,500
| -49% | -$811K |
2016 Q1
17 quarters
|
|
2641
Opera Ltd
OPRA
$1.56B
| $829K | ﹤0.01% |
92,100
+38,685
| +72% | +$241K |
2019 Q3
3 quarters
|
|
|
2642
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
| $825K | ﹤0.01% |
+4,911,306
| New | +$1.38M |
2020 Q2
0 quarters
|
|
|
CTK
2643
DELISTED
CooTek (Cayman) Inc. American Depositary Shares, each representing 650 Class A Ordinary Shares
CTK
| $824K | ﹤0.01% |
8,929
+2,304
| +35% | +$207K |
2020 Q1
1 quarter
|
|
|
ITMR
2644
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $824K | ﹤0.01% |
44,300
+3,220
| +8% | +$50.7K |
2020 Q1
1 quarter
|
|
2645
Unifirst Corp
UNF
$4.72B
| $823K | ﹤0.01% |
4,601
-27,000
| -85% | -$4.52M |
2013 Q2
28 quarters
|
|
2646
DELISTED
Taitron Components
TAIT
| $822K | ﹤0.01% |
312,401
+14,940
| +5% | +$37K |
2016 Q2
16 quarters
|
|
2647
DELISTED
Evans Bancorp Inc
EVBN
| $821K | ﹤0.01% |
35,283
+2,160
| +7% | +$53K |
2016 Q4
14 quarters
|
|
2648
Global X Silver Miners ETF NEW
SIL
$4.44B
| $818K | ﹤0.01% |
+22,100
| New | +$718K |
2020 Q2
0 quarters
|
|
|
BOCH
2649
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $818K | ﹤0.01% |
107,900
-4,400
| -4% | -$32.2K |
2015 Q4
18 quarters
|
|
2650
HF Foods Group
HFFG
$87.9M
| $811K | ﹤0.01% |
+89,600
| New | +$652K |
2020 Q2
0 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.